← Leaderboards
Martin Cheever
Corixa Corporation
$30,751,750
Attributed
$30,751,750
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.8M · FY2010–19$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$30,751,750 · 5
By mechanism
U01$16,826,049 · 1
UM1$13,090,841 · 1
R37$557,134 · 1
R01$277,726 · 1
M01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Member”
- David R. Weir · University Of Michigan At Ann Arbor$340,329,837
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Barton F Haynes · Duke University$312,190,812
- Jeffrey P Krischer · University Of South Florida$296,624,284
- Norman Wolmark · Nsabp Foundation, Inc.$262,548,790
Research focus
MemberConduct Clinical TrialsCredentialingCancer ImmunotherapyLeadershipMalignant NeoplasmsOperationStatistical CenterClinical TrialsInstitutionSpecimenImmunotherapeutic AgentCancer TherapyResearch InfrastructureUniversitiesT-LymphocyteEducational WorkshopImmune ResponseResearch PersonnelFutureImmunotherapyBiological MarkersBiologicalFred Hutchinson Cancer Research Center
Grant awards (16)
Cancer Immunotherapy Trials Network Central Operations and Statistical Center$3,531,526
UM1 · FY2019 · CA · contact PI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center$4,864,165
UM1 · FY2018 · CA · contact PI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center$4,695,150
UM1 · FY2017 · CA · contact PI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center$2,100,000
U01 · FY2017 · CA · contact PI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center$2,037,244
U01 · FY2016 · CA · contact PI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center$2,654,299
U01 · FY2015 · CA · contact PI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center$2,667,211
U01 · FY2014 · CA · contact PI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center$910,425
U01 · FY2013 · CA · contact PI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center$3,368,475
U01 · FY2012 · CA · contact PI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center$1,564,718
U01 · FY2011 · CA · contact PI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center$1,523,677
U01 · FY2010 · CA · contact PI
SPECIFIC IMMUNOTHERAPY OF MURINE TUMORS$278,567
R37 · FY2002 · CA
ASPIRATION FROM PATIENTS WITH HEMATOLOGY DISORDERS$0
M01 · FY2002 · RR
ASPIRATION FROM PATIENTS WITH HEMATOLOGY DISORDERS$0
M01 · FY2001 · RR
SPECIFIC IMMUNOTHERAPY OF MURINE TUMORS$278,567
R37 · FY2000 · CA
RAS-SPECIFIC T CELL MEDIATED IMMUNOTHERAPY$277,726
R01 · FY2000 · CA